Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
Marta ZubkowiczJürgen HeldMichael BaierMathias W PletzMiriam KesselmeierStefan HagelChristina ForstnerPublished in: Mycoses (2020)
A positive test result of both BDG assays at manufacturer's cut-off was highly predictive for IFD, but except for Pneumocystis jirovecii pneumonia sensitivities were limited. Adjustment of the GT cut-off value equalised sensitivities of GT and FA.